Asset icon - trade crypto, stocks, and gold on Pluang
Trade on Pluang
One platform for all markets
Download
Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Acadia Healthcare Company Inc (ACHC) vs Strategy Inc. (MSTR) Price & Performance

Acadia Healthcare Company Inc
Strategy Inc.

Price performance

Price movement over the last 24 hours

Key statistics

Acadia Healthcare Company Inc vs Strategy Inc. — how do they compare? Acadia Healthcare Company Inc trades at $30.88 (market cap $2.94B), while Strategy Inc. trades at $93.99 (market cap $34.83B). The key difference: Strategy Inc. is far larger — about 11.8× Acadia Healthcare Company Inc's market cap, and Acadia Healthcare Company Inc is trading nearer its 52-week high, Strategy Inc. nearer its low. Which is the better fit depends on your goals.

ACHCMSTR
Market Cap
$2.94B$34.83B
Sector
HealthTechnology
52-Week High
$31.92$455.90
52-Week Low
$11.68$82.31
Enterprise Value
$5.45B$49.87B

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Acadia Healthcare Company Inc

ACHC trades at $31.09, down 2.57% today but maintains a bullish technical outlook with strong moving average support. The company shows operational strength with three consecutive earnings beats, though profitability remains challenged with a -32.84% net margin. Analyst consensus is strongly bullish with 68% buy ratings, while recent news highlights the company's strategic shift toward profitability and rising behavioral health demand.

The stock presents a mixed opportunity with strong technical momentum and analyst support offset by persistent profitability challenges. Key catalysts include continued earnings outperformance and successful execution of the turnaround strategy, while risks center on margin pressures and high short interest that could limit upside potential.

Strategy Inc.

MSTR stock trades at $97.36, down 3.38% on the day, with a bearish technical signal. The company reported a net loss of $3.85 billion in 2025, with a negative net income margin of -806.35%. Recent news highlights a strategic shift, including a $216 million Bitcoin sale to support preferred stock obligations, marking a departure from its previous 'never sell' stance. Analyst consensus remains largely positive with a $253 price target, but fundamental metrics show significant strain from persistent losses.

The outlook is clouded by deep profitability challenges and high volatility linked to digital asset holdings. Investment opportunity hinges on successful execution of the new capital management framework, but risks include further Bitcoin price declines and inability to achieve sustainable earnings. The stock's trajectory will depend heavily on balancing treasury management with core business performance.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About Acadia Healthcare Company Inc

Acadia Healthcare is a leading provider of behavioral healthcare services across the US and Puerto Rico. It operates a network of psychiatric hospitals, residential treatment centers, and clinics for mental health and addiction recovery.

Read more on ACHC

About Strategy Inc.

MicroStrategy Inc is a provider of enterprise analytics and mobility software. It offers MicroStrategy Analytics platform that delivers reports and dashboards and enables users to conduct ad hoc analysis and share insights through mobile devices or the Web

Read more on MSTR